Kirsten L. Cleary, MD

Board Certifications: 
Maternal-Fetal Medicine, Obstetrics and Gynecology
Accepting New Patients
Profile Hero

Overview

Areas of Expertise / Conditions Treated

Preterm Birth Prevention

Academic Appointments

  • Assistant Professor of Obstetrics & Gynecology at CUMC

Administrative Titles

  • Director, Antepartum Service & Perinatal Network Hospitals

Kirsten Lawrence Cleary, MD – Co-Director, The Mothers Center at Columbia University Medical Center

Kirsten Lawrence Cleary is a member of the Division of Maternal-Fetal Medicine (MFM) in the Department of Obstetrics and Gynecology. Dr. Cleary graduated cum laude from Wellesley College. After completing her residency in Obstetrics and Gynecology at New York University/Bellevue, Dr. Cleary did a fellowship in Maternal-Fetal Medicine at the University of Pennsylvania. She also completed a Masters Degree in Clinical Epidemiology and Biostatistics at Penn, where her thesis focused on infectious disease screening in pregnancy.

Dr. Cleary came to Columbia in 2004, where she has worked as a core member of our Obstetrics team, with a strong clinical and research interest in hypertensive diseases in pregnancy, maternal cardiac disease and critical care obstetrics. She is the director of the Perinatal Networks for our Regional Perinatal Center, facilitating transfer for high risk patients from the region to our center.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Lawrence Hospital

Gender

  • Female

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-7334

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • University of Connecticut School of Medicine
  • Residency: New York University Medical Center
  • Fellowship: Hospital of the University of Pennsylvania

Board Certifications

  • Maternal-Fetal Medicine
  • Obstetrics and Gynecology

Honors & Awards

  • Bellevue Hospital Center, Annual Patient Appreciation Award

Research

Grants

PROSPECTIVE RANDOMIZED DOUBLE BLIND, PLACEBO CONTROLLED EVALUATION OF THE PHARMACOKINETICS, SAFETY AND EFFICACY OF RECOMBINANT ANTITHROMBIN VERSUS PLACEBO IN PRETERM PREECLAMPSIA (PRESERVE-1) (P&S Industry Clinical Trial)

Oct 3 2014 - Oct 3 2019

CHRONIC HYPERTENSION AND PREGNANCY (CHAP) (Federal Gov)

Oct 1 2014 - May 31 2019

MATERNAL OUTCOMES AND NEURODEVELOPMENTAL EFFECTS OF ANTIEPILEPTIC DRUGS (Federal Gov)

Aug 1 2012 - Jul 31 2017

PHARMACOKINETIC AND PHARMACOGENOMIC APPROACH TO INDOMETHACIN THERAPY IN PREGNANCY (Federal Gov)

Mar 1 2016 - Feb 28 2017

CESAREAN SECTION OPTIMAL ANTIBIOTIC PROPHYLAXIS (C/SOAP) TRIAL (Federal Gov)

Nov 1 2013 - Jul 31 2015

PRAVASTATIN FOR THE PREVENTION OF PRE-ECLAMPSIA IN HIGH RISK WOMAN (Federal Gov)

Jan 1 2013 - Dec 31 2013